Decoding the PTTG family's contribution to LUAD pathogenesis: a comprehensive study on expression, epigenetics, and...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung adenocarcinoma (LUAD) is a common cancer with poorly understood mechanisms.
• The pituitary tumor-transforming gene (PTTG) family's role in LUAD is largely unexplored.

Purpose of the Study:

• To investigate the role of the PTTG family (PTTG1, PTTG2, PTTG3P) in lung adenocarcinoma (LUAD).
• To evaluate the diagnostic, prognostic, and therapeutic implications of the PTTG family in LUAD.

Main Methods:

• Analysis of clinical LUAD samples and expression datasets.
• Promoter methylation and mutational analyses.
• Functional assays (gene knockdown) and molecular docking studies.
• Drug screening using the DrugBank database.

Main Results:

• PTTG family genes are significantly upregulated in LUAD tissues and cell lines.
• PTTG gene expression is linked to adverse patient survival outcomes.
• Knockdown of PTTG1 and PTTG2 inhibits LUAD cell proliferation, migration, and colony formation.
• Calcitriol identified as a potential therapeutic agent to down-regulate PTTG genes, with strong molecular docking interactions.

Conclusions:

• The PTTG family plays a significant role in LUAD pathogenesis.
• PTTG genes serve as potential diagnostic and prognostic biomarkers for LUAD.
• Calcitriol represents a promising therapeutic strategy for LUAD by targeting the PTTG family.